Andreas Goutopoulos

1.6k total citations
27 papers, 1.2k citations indexed

About

Andreas Goutopoulos is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andreas Goutopoulos has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andreas Goutopoulos's work include Cannabis and Cannabinoid Research (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Forensic Toxicology and Drug Analysis (7 papers). Andreas Goutopoulos is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Forensic Toxicology and Drug Analysis (7 papers). Andreas Goutopoulos collaborates with scholars based in United States, Switzerland and Italy. Andreas Goutopoulos's co-authors include Alexandros Makriyannis, Daniele Piomelli, S. Lin, Sonyuan Lin, Massimiliano Beltramo, Xiang‐Qun Xie, Atmaram D. Khanolkar, Pusheng Fan, Cheng‐Ta Li and Darren Fegley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Andreas Goutopoulos

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Goutopoulos United States 16 911 575 253 172 147 27 1.2k
Hongfeng Deng United States 11 798 0.9× 498 0.9× 254 1.0× 144 0.8× 45 0.3× 15 1.1k
Amy D. Sinor United States 8 484 0.5× 501 0.9× 276 1.1× 44 0.3× 58 0.4× 10 958
Angela B. Clement Germany 11 358 0.4× 219 0.4× 214 0.8× 48 0.3× 47 0.3× 11 656
Clara Andradas Spain 13 678 0.7× 273 0.5× 324 1.3× 29 0.2× 19 0.1× 16 972
David M. Putman Canada 7 332 0.4× 190 0.3× 150 0.6× 46 0.3× 36 0.2× 9 537
Eiron Cudaback United States 15 345 0.4× 201 0.3× 207 0.8× 20 0.1× 49 0.3× 22 812
Margarita Suardíaz Spain 12 240 0.3× 160 0.3× 174 0.7× 26 0.2× 58 0.4× 17 591
Silvia Pontis Italy 15 228 0.3× 157 0.3× 271 1.1× 10 0.1× 50 0.3× 30 745
Hengjun He United States 7 204 0.2× 190 0.3× 209 0.8× 73 0.4× 31 0.2× 8 456
Yves Mérand Canada 24 89 0.1× 308 0.5× 545 2.2× 107 0.6× 43 0.3× 49 1.6k

Countries citing papers authored by Andreas Goutopoulos

Since Specialization
Citations

This map shows the geographic impact of Andreas Goutopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Goutopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Goutopoulos more than expected).

Fields of papers citing papers by Andreas Goutopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Goutopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Goutopoulos. The network helps show where Andreas Goutopoulos may publish in the future.

Co-authorship network of co-authors of Andreas Goutopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Goutopoulos. A scholar is included among the top collaborators of Andreas Goutopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Goutopoulos. Andreas Goutopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perets, Ruth, Meredith McKean, Andreas Goutopoulos, et al.. (2022). Phase 1 first-in-human trial of MTB-9655, the first oral inhibitor of ACSS2, in patients with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). e20609–e20609. 6 indexed citations
2.
Goutopoulos, Andreas, et al.. (2022). Abstract 2326: Preclinical characterization of MTB-9655, a first-in-class, clinical stage ACSS2 inhibitor. Cancer Research. 82(12_Supplement). 2326–2326.
3.
Yarchoan, Mark, John D. Powderly, Bruno R. Bastos, et al.. (2022). A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 3005–3005. 5 indexed citations
4.
Ali, Zahid, Richard D. Caldwell, A.S. Gardberg, et al.. (2021). Discovery of Covalent Bruton's Tyrosine Kinase Inhibitors with Decreased CYP2C8 Inhibitory Activity. ChemMedChem. 16(24). 3653–3662. 1 indexed citations
5.
Goutopoulos, Andreas, Omri Erez, Iris Alchanati, et al.. (2020). Abstract LB-295: Discovery of potent selective oral ACSS2 inhibitors for the treatment of acetate avid tumors. Cancer Research. 80(16_Supplement). LB–295.
6.
Xiao, Yufang, Srinivasa Karra, Andreas Goutopoulos, et al.. (2019). Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 29(13). 1660–1664. 9 indexed citations
7.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit. Bioorganic & Medicinal Chemistry Letters. 28(17). 2939–2944. 19 indexed citations
8.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(20). 3307–3311. 4 indexed citations
9.
Caldwell, Richard D., Lesley Liu‐Bujalski, Igor Mochalkin, et al.. (2018). Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. Bioorganic & Medicinal Chemistry Letters. 28(21). 3419–3424. 15 indexed citations
10.
Karra, Srinivasa, Yufang Xiao, Xiaoling Chen, et al.. (2013). SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3081–3087. 15 indexed citations
11.
Kım, Kihyun, Sun‐Young Kong, Mariateresa Fulciniti, et al.. (2010). Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity in vitro and in vivo. British Journal of Haematology. 149(4). 537–549. 100 indexed citations
12.
Salvat, Catherine, Alessandro Di Cara, David Fischer, et al.. (2009). Functional Whole-genome Analysis Identifies Polo-like Kinase 2 and Poliovirus Receptor as Essential for Neuronal Differentiation Upstream of the Negative Regulator αB-crystallin. Journal of Biological Chemistry. 284(46). 32053–32065. 19 indexed citations
13.
Goutopoulos, Andreas & Alexandros Makriyannis. (2002). From cannabis to cannabinergics. Pharmacology & Therapeutics. 95(2). 103–117. 80 indexed citations
14.
Goutopoulos, Andreas, et al.. (2001). Stereochemical Selectivity of Methanandamides for the CB1 and CB2 Cannabinoid Receptors and Their Metabolic Stability. Bioorganic & Medicinal Chemistry. 9(7). 1673–1684. 37 indexed citations
15.
Lamb, R. J., et al.. (2000). Effects of Δ9-tetrahydrocannabinol, (R)-methanandamide, SR 141716, and d-amphetamine before and during daily Δ9-tetrahydrocannabinol dosing. European Journal of Pharmacology. 398(2). 251–258. 19 indexed citations
16.
Gifford, Andrew N., Sonyuan Lin, Andreas Goutopoulos, et al.. (1999). Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). European Journal of Pharmacology. 383(1). 9–14. 48 indexed citations
17.
Piomelli, Daniele, Massimiliano Beltramo, S. Lin, et al.. (1999). Structural determinants for recognition and translocation by the anandamide transporter. Proceedings of the National Academy of Sciences. 96(10). 5802–5807. 229 indexed citations
18.
19.
Lamb, R. J., et al.. (1998). Δ 9 -THC training dose as a determinant for ( R )-methanandamide generalization in rats. Psychopharmacology. 140(4). 519–522. 46 indexed citations
20.
Lin, Sonyuan, et al.. (1998). Novel Analogues of Arachidonylethanolamide (Anandamide):  Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability. Journal of Medicinal Chemistry. 41(27). 5353–5361. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongfeng Deng Breakdown of academic impact, for papers by Amy D. Sinor Breakdown of academic impact, for papers by Angela B. Clement Breakdown of academic impact, for papers by Clara Andradas Breakdown of academic impact, for papers by David M. Putman Breakdown of academic impact, for papers by Eiron Cudaback Breakdown of academic impact, for papers by Margarita Suardíaz Breakdown of academic impact, for papers by Silvia Pontis Breakdown of academic impact, for papers by Hengjun He Breakdown of academic impact, for papers by Yves Mérand
Rankless by CCL
2026